This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Nanosphere Inc
NSPH : NASDAQ : Health Care
$0.23 -0.01 | -4.80%
Today's Range: 0.22 - 0.24
Avg. Daily Volume: 1,609,300
01/26/15 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
NSPH NANOSPHERE INC 0.26 30.50 n/m 13.06 60.07
CYTX CYTORI THERAPEUTICS INC 0.48 44.38 n/m 7.29 -54.62
CLSN CELSION CORP 2.21 44.15 n/m 0.50 33.33
OGXI ONCOGENEX PHARMACEUTICALS 2.06 43.84 n/m 30.07 -3.20
ENZN ENZON PHARMACEUTICALS INC 0.99 43.70 1.55 32.33 -14.28
IBIO IBIO INC 0.52 37.39 n/m 1.06 61.46
OGEN ORAGENICS INC 0.83 30.03 n/m 1.15 12.25
PTN PALATIN TECHNOLOGIES INC 0.70 27.64 n/m 4.93 82100.00
RXII RXI PHARMACEUTICALS CORP 1.21 25.57 n/m 0.09 -79.03
HART HARVARD APPARATUS REGN TECH 3.21 25.22 n/m 0.07 n/a
XTLB XTL BIOPHARMACEUTICALS 1.98 23.48 n/m 1.97 -12.79
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

NSPH Ind Avg S&P 500
n/m 83.11 19.47

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs